Recto, Rudita .
HRN: 14-79-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2022
CEFTRIAXONE 1G (VIAL)
09/12/2022
09/18/2022
IVT
2g
OD
Presumptive TB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes